Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Intangibles: 2010-2024

Historic Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Dec 2024 value amounting to $18.0 million.

  • Cumberland Pharmaceuticals' Intangibles fell 22.69% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 22.69%. This contributed to the annual value of $18.0 million for FY2024, which is 20.50% down from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Intangibles is $18.0 million, which was down 20.50% from $22.6 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Intangibles registered a high of $30.6 million during FY2022, and its lowest value of $18.0 million during FY2024.
  • Moreover, its 3-year median value for Intangibles was $22.6 million (2023), whereas its average is $23.7 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Intangibles climbed by 27.70% in 2022 and then fell by 26.10% in 2023.
  • Cumberland Pharmaceuticals' Intangibles (Yearly) stood at $28.1 million in 2020, then dropped by 14.81% to $24.0 million in 2021, then rose by 27.70% to $30.6 million in 2022, then decreased by 26.10% to $22.6 million in 2023, then declined by 20.50% to $18.0 million in 2024.